Your browser doesn't support javascript.
loading
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).
Crabb, Simon J; Danson, Sarah; Catto, James W F; Hussain, Syed; Chan, Danna; Dunkley, Denise; Downs, Nichola; Marwood, Ellice; Day, Laura; Saunders, Geoff; Light, Michelle; Whitehead, Amy; Ellis, Deborah; Sarwar, Naveed; Enting, Deborah; Birtle, Alison; Johnson, Bernadette; Huddart, Robert; Griffiths, Gareth.
Afiliação
  • Crabb SJ; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom. S.J.Crabb@southampton.ac.uk.
  • Danson S; University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom.
  • Catto JWF; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, England, United Kingdom.
  • Hussain S; Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, University of Sheffield, Sheffield, England, United Kingdom.
  • Chan D; Academic Urology Unit, University of Sheffield, Sheffield, England, United Kingdom.
  • Dunkley D; Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, University of Sheffield, Sheffield, England, United Kingdom.
  • Downs N; Astex Pharmaceuticals, Inc., Pleasanton, California.
  • Marwood E; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom.
  • Day L; University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom.
  • Saunders G; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, England, United Kingdom.
  • Light M; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom.
  • Whitehead A; University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom.
  • Ellis D; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom.
  • Sarwar N; University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom.
  • Enting D; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom.
  • Birtle A; University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom.
  • Johnson B; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom.
  • Huddart R; University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom.
  • Griffiths G; Southampton Clinical Trials Unit, University of Southampton, Southampton, England, United Kingdom.
Clin Cancer Res ; 27(7): 1882-1892, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33472913
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos